ABSTRACT
The sensory and aroma quality of 30% (w/w) sucrose reduced sponge cakes incorporating clean-label replacers were investigated. The sensory quality of the reformulated sponge cakes varied, with those containing apple pomace powder (APP) showing the greatest difference to the control (SC100). Volatile profiles mainly differed in relation to compounds derived from the Maillard reaction, caramelisation and lipid oxidation. Thrity six aroma active volatile compounds were identified in the SC100, APP and oligofructose (OLIGO) sponge cakes by olfactometry. Furfural 'spicy bready' contributed most to the overall aroma of all samples, with factor dilution values differing the most for heptanal 'fatty cake crust', methional 'potato damp', and 2,5-dimethylpyrazine 'cake crust, nutty'. This study provides an in-depth insight into the impact of sugar reduction reformulation on the sensory perception of sponge cakes and demonstrates how this approach can be used to improve the sensory perception of reduced sucrose sponge cakes.
Subject(s)
Bread/analysis , Volatile Organic Compounds/analysis , Adult , Gas Chromatography-Mass Spectrometry , Humans , Middle Aged , Odorants/analysis , Olfactometry , Sensory Thresholds , Solid Phase Microextraction , Sucrose/chemistry , Volatile Organic Compounds/isolation & purification , Young AdultABSTRACT
Saline water from a storm surge can flow down storm-damaged submerged water supply wells and contaminate boreholes and surrounding aquifers. Using data from conventional purging techniques, aquifer test response analysis, chemical analysis, and regression analysis of chloride/silica (Cl/Si) ratio, equations were derived to estimate the volume of saline water intrusion into a well and a porous media aquifer, the volume of water needed to purge a well shortly following an intrusion event, and the volume of water needed after delay of several or more months, when the saline plume has expanded. Purging time required is a function of volume of water and pumping rate. The study site well is located within a shoreline community of Lake Pontchartrain, St. Tammany Parish, in southeastern Louisiana, United States, which was impacted by two hurricane storm surges and had neither been rehabilitated nor chlorinated prior to our study. Chemical analysis of water samples in fall 2005 and purging of well and aquifer in June 6, 2006, indicated saline water had intruded the well in 2005 and the well and aquifer in 2006. The volume of water needed to purge the study well was approximately 200 casing volumes, which is significantly greater than conventionally used during collection of water samples for water quality analyses.
Subject(s)
Chlorides/analysis , Water Pollutants, Chemical/analysis , Water Supply/analysis , Calcium/analysis , Disasters , Louisiana , Magnesium/analysis , Silicon/analysis , Water MovementsABSTRACT
The literature surrounding rodent models of human anxiety disorders is discrepant concerning which models reflect anxiety-like behavior distinct from general activity and whether different models are measuring the same underlying constructs. This experiment compared the responses of 15 inbred mouse strains (129S1/SvlmJ, A/J, AKR/J, BALB/cByJ, C3H/HeJ, C57BL/6J, C57L/J, CBA/J, CE/J, DBA/2J, FVB/NJ, NZB/B1NJ, PL/J, SJL/J and SWR/J) in three anxiety-like behavioral tasks (light/dark test, elevated zero-maze and open field) to examine whether responses were phenotypically and/or genetically correlated across tasks. Significant strain differences were found for all variables examined. Principal components analyses showed that variables associated with both activity and anxiety-like behaviors loaded onto one factor, while urination and defecation loaded onto another factor. Our findings differ from previous research by suggesting that general activity and anxiety-related behaviors are linked, negatively correlated and cannot easily be dissociated in these assays. However, these findings may not necessarily generalize to other unconditioned anxiety-like behavioral tests.
Subject(s)
Anxiety Disorders/genetics , Anxiety Disorders/psychology , Behavior, Animal/physiology , Genetic Predisposition to Disease/genetics , Animals , Anxiety/diagnosis , Anxiety/genetics , Anxiety/psychology , Anxiety Disorders/diagnosis , Defecation/genetics , Disease Models, Animal , Exploratory Behavior/physiology , Fear/physiology , Female , Male , Maze Learning/physiology , Mice , Mice, Inbred Strains , Motor Activity/physiology , Neuropsychological Tests , Phenotype , Principal Component Analysis , Species Specificity , Urination/geneticsABSTRACT
Stem cell fate is influenced by specialized microenvironments that remain poorly defined in mammals. To explore the possibility that haematopoietic stem cells derive regulatory information from bone, accounting for the localization of haematopoiesis in bone marrow, we assessed mice that were genetically altered to produce osteoblast-specific, activated PTH/PTHrP receptors (PPRs). Here we show that PPR-stimulated osteoblastic cells that are increased in number produce high levels of the Notch ligand jagged 1 and support an increase in the number of haematopoietic stem cells with evidence of Notch1 activation in vivo. Furthermore, ligand-dependent activation of PPR with parathyroid hormone (PTH) increased the number of osteoblasts in stromal cultures, and augmented ex vivo primitive haematopoietic cell growth that was abrogated by gamma-secretase inhibition of Notch activation. An increase in the number of stem cells was observed in wild-type animals after PTH injection, and survival after bone marrow transplantation was markedly improved. Therefore, osteoblastic cells are a regulatory component of the haematopoietic stem cell niche in vivo that influences stem cell function through Notch activation. Niche constituent cells or signalling pathways provide pharmacological targets with therapeutic potential for stem-cell-based therapies.
Subject(s)
Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Osteoblasts/cytology , Osteoblasts/metabolism , Signal Transduction , Animals , Bone and Bones/cytology , Bone and Bones/metabolism , Calcium-Binding Proteins , Cell Count , Cell Division/drug effects , Cell Survival/drug effects , Environment , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/drug effects , Intercellular Signaling Peptides and Proteins , Jagged-1 Protein , Ligands , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Osteoblasts/drug effects , Parathyroid Hormone/pharmacology , Proteins/metabolism , Rats , Receptor, Parathyroid Hormone, Type 1/metabolism , Receptors, Notch , Receptors, Parathyroid Hormone/metabolism , Serrate-Jagged Proteins , Signal Transduction/drug effects , Stromal Cells/cytology , Stromal Cells/drug effects , Stromal Cells/metabolismABSTRACT
Notch signaling is involved in the regulation of many cell fate determination events in both embryonic development and adult tissue homeostasis. We previously demonstrated that Notch1 and Notch2 molecules inhibit myeloid differentiation in a cytokine-specific manner and that the Notch cytokine response domain is necessary for this functional specificity. We have now investigated the putative role of phosphorylation in the activity of Notch in response to cytokine signals. Our results show that the granulocyte colony-stimulating factor (G-CSF) stimulation of 32D cells expressing the intracellular Notch2 protein induces phosphorylation at specific sites of this molecule, rendering the molecule inactive and permitting differentiation of these cells. In contrast, when cells are stimulated with granulocyte macrophage colony-stimulating factor (GM-CSF), intracellular notch2 is not phosphorylated at these residues and differentiation is inhibited. We also show that deletion of the Ser/Thr-rich region between amino acids 2067 and 2099 abrogates G-CSF-induced phosphorylation and results in a molecule that inhibits differentiation in response to either G-CSF or GM-CSF. Our results further indicate that Ser(2078) is a critical residue for phosphorylation and modulation of Notch2 activity in the context of G-CSF-induced differentiation of 32D cells.
Subject(s)
Phosphorylation , Receptors, Cell Surface/physiology , Serine/chemistry , Amino Acid Sequence , Amino Acids/chemistry , Animals , Blotting, Western , Cell Differentiation , Cells, Cultured , Cytokines/metabolism , Gene Deletion , Granulocyte Colony-Stimulating Factor/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Immunoblotting , Mice , Microscopy, Fluorescence , Molecular Sequence Data , Plasmids/metabolism , Protein Structure, Tertiary , Rats , Receptor, Notch2 , Receptors, Cell Surface/metabolism , Sequence Homology, Amino Acid , Signal Transduction , Threonine/chemistry , Time Factors , Transcriptional ActivationABSTRACT
OBJECTIVE: Major histocompatibility class II (MHC II) molecules are among the earliest antigens to be expressed in hematopoietic progenitor cells; however, the functional role of these molecules in hematopoiesis remains controversial. We examined the role of MHC II antigens during hematopoiesis using a mouse model of MHC II deficiency related to the absence of the critical transcriptional activator, CIITA. METHODS: Sca-1(-), Sca-1(+)lin(+), and Sca-1(+)lin(-) populations of marrow cells from CIITA(-)(/-) and wild-type mice were analyzed by immunofluorescence for MHC II expression. Hematopoietic capacity was assessed in CIITA(-/-) and wild-type mice by CFU-S, CFU-GM, and radiation sensitivity assays. RESULTS: Flow cytometric characteristics of hematopoietic progenitors from CIITA(-/-) and wild-type mice were identical except for the absence of MHC II expression in CIITA null mice. There were no significant differences in capacity for hematopoietic reconstitution and clonogenicity as measured by radiation sensitivity, CFU-S, and CFU-GM assays among CIITA(-/-) and wild-type mice. CONCLUSIONS: These experiments show that downregulation of MHC II gene transcription does not effectively alter normal hematopoiesis, and provide strong evidence that MHC II expression on hematopoietic progenitors is not required for normal hematopoietic development.
Subject(s)
Hematopoiesis/drug effects , Histocompatibility Antigens Class II/pharmacology , Mice, Knockout , Nuclear Proteins , Rodent Diseases/immunology , Severe Combined Immunodeficiency/veterinary , Animals , Bone Marrow Cells/cytology , Colony-Forming Units Assay , Disease Models, Animal , Flow Cytometry , Hematopoiesis/radiation effects , Hematopoietic Stem Cells/cytology , Histocompatibility Antigens Class II/physiology , Mice , Rodent Diseases/genetics , Severe Combined Immunodeficiency/genetics , Severe Combined Immunodeficiency/immunology , Trans-Activators/genetics , Trans-Activators/pharmacology , Whole-Body Irradiation/mortalityABSTRACT
Herbicide-resistant populations of Alopecurus myosuroides Huds (black-grass) have become widespread throughout the UK since the early 1980s. Clear evidence suggests that more than one resistance mechanism exists, and glutathione S-transferases (GSTs) have been implicated in resistance due to enhanced metabolism. This study reports the determination of GST activity in four UK black-grass populations from field sites situated in the East Midlands. Data demonstrate that, as untreated plants in the field mature, there is an accompanying natural elevation of GST activity with natural environmental changes from winter to spring. We speculate that this endogenous change in enzyme activity with plant development in the field contributes to reduced efficacy of some graminicides applied in the spring. These observations are discussed in relation to predicting herbicide efficacy to achieve maximum control of this important grass weed.
Subject(s)
Glutathione Transferase/metabolism , Herbicides/administration & dosage , Plant Leaves/enzymology , Poaceae/enzymology , Agriculture , Climate , Drug Resistance , Plant Leaves/drug effects , Plant Leaves/growth & development , Plant Proteins/isolation & purification , Plant Proteins/metabolism , Poaceae/drug effects , Poaceae/growth & development , Seasons , United KingdomABSTRACT
The Notch genes encode single-pass transmembrane receptors that transduce the extracellular signals responsible for cell fate determination during several steps of metazoan development. The mechanism by which extracellular signals affect gene transcription and ultimately cell fate decisions is beginning to emerge for the Notch signalling pathway. One paradigm is that ligand binding to Notch triggers a Presenilin1-dependent proteolytic release of the Notch intracellular domain from the membrane, resulting in low amounts of Notch intracellular domain which form a nuclear complex with CBF1/Su(H)/Lag1 to activate transcription of downstream targets. Not all observations clearly support this processing model, and the most rigorous test of it is to block processing in vivo and then determine the ability of unprocessed Notch to signal. Here we report that the phenotypes associated with a single point mutation at the intramembranous processing site of Notch1, Val1,744-->Gly, resemble the null Notch1 phenotype. Our results show that efficient intramembranous processing of Notch1 is indispensable for embryonic viability and proper early embryonic development in vivo.
Subject(s)
Embryonic and Fetal Development/physiology , Membrane Proteins/physiology , Protein Processing, Post-Translational , Receptors, Cell Surface , Transcription Factors , Alleles , Animals , Cloning, Molecular , Embryo, Mammalian , Embryonic and Fetal Development/genetics , Fetal Death/genetics , Gene Targeting , Germ-Line Mutation , Homozygote , Immunoglobulins , In Situ Hybridization , Ligands , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Phenotype , Point Mutation , Protein Processing, Post-Translational/genetics , Receptor, Notch1 , Receptors, Cytokine/biosynthesisABSTRACT
Autosomal recessive polycystic kidney disease (ARPKD) is a hereditary condition with an estimated incidence of 1 in 20,000 live births. Various growth factors have been implicated in the causation of this disease. We describe a child with ARPKD whose levels of urinary basic fibroblast growth factor (bFGF) were markedly elevated. The concentrations of bFGF increased further following right nephrectomy, in response to the compensatory growth of the remaining kidney. We hypothesize that measurement of urinary bFGF may be useful as a noninvasive marker to assess progression of cystic renal development.
Subject(s)
Fibroblast Growth Factor 2/urine , Polycystic Kidney, Autosomal Recessive/urine , Adult , Biomarkers/urine , Child, Preschool , Disease Progression , Female , Humans , Male , Nephrectomy , Polycystic Kidney, Autosomal Recessive/pathology , Polycystic Kidney, Autosomal Recessive/surgeryABSTRACT
Developing male Sprague-Dawley rats (125 g) with adriamycin (doxorubicin hydrochloride) nephrosis (AN) were treated with growth hormone (GH) which may induce hyperfiltration potentiating glomerulosclerosis. Since captopril (CAP) reduces hyperfiltration, we studied its effects in GH-treated rats with AN. After 41, 76, and 90 days of therapy, urine protein excretion was significantly (P<0.05) reduced in GH-treated AN plus CAP compared with AN rats receiving GH alone. After 90 days, urine protein, creatinine ratio was significantly (P<0.05) increased in GH-treated AN (95.2+/-13.9) compared with untreated AN (64.8+/-7.8) and GH-treated AN rats plus CAP (41.8+/-8.8). The mean serum cholesterol level was significantly (P<0.05) reduced in GH-treated AN rats receiving CAP compared with AN rats receiving GH alone and untreated AN controls. Histologically tubular dilation was significantly (P<0.05) reduced in GH-treated AN rats plus CAP compared with AN rats receiving GH alone. Tubular atrophy and scarring were significantly (P<0.05) increased in AN rats treated with GH compared with untreated AN rats, and normalized in GH-treated AN rats plus CAP. We conclude that CAP reduces the proteinuric response of GH in rats with AN and ameliorates tubular injury.
Subject(s)
Captopril/therapeutic use , Doxorubicin , Growth Hormone/adverse effects , Kidney Diseases/chemically induced , Proteinuria/drug therapy , Animals , Cholesterol/blood , Disease Models, Animal , Male , Proteinuria/chemically induced , Proteinuria/pathology , Rats , Rats, Sprague-DawleySubject(s)
Hematopoiesis/physiology , Membrane Proteins/physiology , Trans-Activators/physiology , Animals , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/physiology , Humans , Mammals , Membrane Proteins/chemistry , Models, Biological , Receptors, Cell Surface/physiology , Receptors, NotchABSTRACT
Patterned spontaneous electrical activity has been demonstrated in a number of developing neural circuits and has been proposed to play a role in refining connectivity once axons reach their targets. Using an isolated spinal cord preparation, we have found that chick lumbosacral motor axons exhibit highly regular bursts of activity from embryonic day 4 (E4) (stage 24-25), shortly after they exit the spinal cord and while still en route toward their target muscles. Similar bursts could be evoked by stimulating descending pathways at cervical or thoracic levels. Unlike older embryonic cord circuits, the major excitatory transmitter driving activity was not glutamate but acetylcholine, acting primarily though nicotinic non-alpha7 receptors. The circuit driving bursting was surprisingly robust and plastic, because bursting was only transiently blocked by cholinergic antagonists, and following recovery, was now driven by GABAergic inputs. Permanent blockade of spontaneous activity was only achieved by a combination of cholinergic antagonists and bicuculline, a GABAA antagonist. The early occurrence of patterned motor activity suggests that it could be playing a role in either peripheral pathfinding or spinal cord circuit formation and maturation. Finally, the characteristic differences in burst parameters already evident between different motoneuron pools at E4 would require that the combination of transcription factors responsible for specifying pool identity to have acted even earlier.
Subject(s)
Acetylcholine/physiology , Motor Neurons/physiology , Neuromuscular Junction/physiology , Proline/analogs & derivatives , gamma-Aminobutyric Acid/physiology , Action Potentials/drug effects , Animals , Bicuculline/pharmacology , Chick Embryo , GABA Antagonists/pharmacology , Glutamic Acid/pharmacology , Nipecotic Acids/pharmacology , Receptors, Nicotinic/physiology , Synaptic Transmission/drug effectsABSTRACT
We analyzed results of 40 infants less than 2 years of age who received bone marrow transplants (BMT) between May 1974 and January 1995 for treatment of acute myelogenous leukemia (AML; N = 34) or myelodysplastic syndrome (MDS; N = 6) to determine outcome and survival performance. Among the AML patients, 13 were in first remission, 9 were in untreated first relapse or second remission, and 12 were in refractory relapse. Patients were conditioned with cyclophosphamide in combination with either total body irradiation (TBI; N = 29) or busulfan (N = 11). Source of stem cells included 6 autologous donors, 15 HLA genotypically identical siblings, 14 haploidentical family members, and 5 unrelated donors. Graft-versus-host disease (GVHD) prophylaxis was methotrexate (MTX) for 17, MTX plus cyclosporine (CSP) for 14, or CSP plus prednisone for 3. Incidence of severe (grade 3-4) regimen-related toxicity was 10% and transplant-related mortality was 10%. Acute GVHD (grades II-III) occurred in 39% of allogeneic patients, and chronic GVHD developed in 40%. Relapse, the most significant problem for patients in this study, occurred in 1 MDS patient and 23 AML patients and was the cause of death for 19 patients. The 2-year probabilities of relapse are 46%, 67%, and 92%, respectively, for patients transplanted in first remission, untreated first relapse or second remission, and relapse. One MDS and 8 AML patients received second marrow transplants for treatment of relapse, and 5 of these survive disease-free for more than 1.5 years. All 6 MDS patients and 11 of 34 AML patients survive more than 1.5 years later. The 5-year probabilities of survival and disease-free survival are 54% and 38% for patients transplanted in first remission and 33% and 22% for untreated first relapse or second remission. None of the patients transplanted with refractory relapse survive disease-free. Outcome was significantly associated with phase of disease at transplantation and pretransplant diagnosis of extramedullary disease. Long-term sequelae included growth failure and hormonal deficiencies. Survival performance was a median of 100% (80% to 100%) and neurologic development for all survivors was appropriate for age. This study indicates that infants with AML have similar outcome after BMT compared with older children and that BMT should be performed in first remission whenever possible. In addition, allogeneic BMT provides effective therapy for the majority of infants with MDS.
Subject(s)
Bone Marrow Transplantation/methods , Leukemia, Myeloid/therapy , Myelodysplastic Syndromes/therapy , Acute Disease , Bone Marrow Transplantation/adverse effects , Bone Marrow Transplantation/mortality , Cause of Death , Disease-Free Survival , Female , Graft vs Host Disease/etiology , Graft vs Host Disease/mortality , Graft vs Host Disease/prevention & control , Growth Disorders/etiology , Humans , Infant , Karnofsky Performance Status , Leukemia, Myeloid/mortality , Male , Myelodysplastic Syndromes/mortality , Recurrence , Remission Induction , Retrospective Studies , Salvage Therapy , Survival Analysis , Survival Rate , Transplantation Conditioning/adverse effects , Transplantation, Homologous , Treatment Failure , Treatment OutcomeABSTRACT
Recent observations regarding the mechanisms of chronic atrial fibrillation (CAF) plus a few encouraging clinical reports have created a paradigm shift regarding treatment strategies and the potential for restoring normal sinus rhythm (NSR) utilizing available catheter-based ablation techniques. The initial and late follow-up clinical experience with a two-staged biatrial linear and focal radiofrequency ablation (BALF I, II) procedure to restore NSR in patients with CAF are described. Pre-BALF management included confirming drug refractoriness and optimizing anticoagulation therapy. BALF I and II were preceded by transesophageal echocardiography to exclude thrombus. Femoral venous catheters were placed in the left atrium and the right atrium with extensive left atrial mapping, ablation (linear and focal) and more limited right atrial ablation. Localized electrogram recordings demonstrated rapid, localized, stable focal driving rotors (FDRs) in the left atrium (nine patients) and in the right atrium (one patient). Atrial or intraatrial tachycardia (IAT) commonly recurred after BALF I. BALF II addresses these recurrences by repeat mapping and ablation techniques. There were no thromboembolic complications. Two patients developed pericardial tamponade that responded to medical management. Of the 11 patients with late follow-up data, 9 have NSR, atrial function, and are no longer experiencing CAF. Left atrial ablation lines decrease continuous electrogram activity, probably isolate portions of the atrium, and unmask FDRs. Focal and linear ablations appear helpful in transforming CAF to NSR. FDRs are commonly localized to pulmonary vein ostium, trabeculated portions of the atrium, and left atrial appendage.
Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/methods , Adult , Aged , Atrial Function , Electrocardiography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Patient Selection , Time FactorsSubject(s)
Adrenal Gland Neoplasms/surgery , Pheochromocytoma/surgery , Adolescent , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/diagnosis , Antihypertensive Agents/therapeutic use , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/drug therapy , Arrhythmias, Cardiac/etiology , Electrocardiography/methods , Humans , Magnetic Resonance Imaging , Male , Pheochromocytoma/complications , Pheochromocytoma/diagnosisABSTRACT
Proper motor function requires the precise matching of motoneuron and muscle fiber properties. The lack of distinguishing markers for early motoneurons has made it difficult to determine whether this matching is established by selective innervation during development or later via motoneuron-muscle fiber interactions. To examine whether chick motoneurons selectively innervate regions of their target containing either fast or slow muscle fibers, we backlabeled neurons from each of these regions with lipophilic dyes. We found that motor axons projecting to fast and slow muscle regions sorted into separate but adjacent fascicles proximally in the limb, long before they reached the muscle. More distally, these fascicles made divergent pathfinding decisions to course directly to the appropriate muscle fiber region. In contrast, axons projecting to different areas of an all-fast muscle did not fasciculate separately and became more intermingled as they coursed through the limb. Selective fasciculation of fast- and slow-projecting motoneurons was similar both before and after motoneuron cell death, suggesting that motoneurons specifically recognized and fasciculated with axons growing to muscle regions containing the appropriate muscle fiber type. Taken together, these results strongly support the hypothesis that "fast" and "slow" motoneurons are molecularly distinct before target innervation and that they use these differences to selectively fasciculate, pathfind to, and branch within the correct muscle fiber region from the outset of neuromuscular development.
Subject(s)
Axons/physiology , Fasciculation/physiopathology , Motor Neurons/physiology , Muscle Fibers, Fast-Twitch/physiology , Muscle Fibers, Slow-Twitch/physiology , Animals , Cell Death , Chick Embryo , Electromyography , Motor Neurons/ultrastructure , Neural Pathways/physiologyABSTRACT
We have compared the ability of two mammalian Notch homologs, mouse Notchl and Notch2, to inhibit the granulocytic differentiation of 32D myeloid progenitor cells. 32D cells undergo granulocytic differentiation when stimulated with either granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF). Expression of the activated intracellular domain of Notch1 inhibits the differentiation induced by G-CSF but not by GM-CSF; conversely, the corresponding domain of Notch2 inhibits differentiation in response to GM-CSF but not to G-CSF. The region immediately C-terminal to the cdc10 domain of Notch confers cytokine specificity on the cdc10 domain. The cytokine response patterns of Notch1 and Notch2 are transferred with this region, which we have termed the Notch cytokine response (NCR) region. The NCR region is also associated with differences in posttranslational modification and subcellular localization of the different Notch molecules. These findings suggest that the multiple forms of Notch found in mammals have structural differences that allow their function to be modulated by specific differentiation signals.
Subject(s)
Granulocyte Colony-Stimulating Factor/physiology , Granulocyte-Macrophage Colony-Stimulating Factor/physiology , Hematopoiesis/physiology , Membrane Proteins/physiology , Receptors, Cell Surface/physiology , Transcription Factors , Amino Acid Sequence , Animals , Binding Sites , Cell Differentiation/physiology , Cell Line , Cloning, Molecular , Granulocytes/cytology , Mice , Molecular Sequence Data , Receptor, Notch1 , Receptor, Notch2ABSTRACT
A cDNA clone encoding the human homolog of rat Jagged1 was isolated from normal human marrow. Analyses of human stromal cell lines indicate that this gene, designated hJagged1, is expressed by marrow stromal cells typified by the cell line HS-27a, which supports the long-term maintenance of hematopoietic progenitor cells. G-CSF-induced differentiation of 32D cells expressing Notch1 was inhibited by coculturing with HS-27a. A peptide corresponding to the Delta/Serrate/LAG-2 domain of hJagged1 and supernatants from COS cells expressing a soluble form of the extracellular portion of hJagged1 were able to mimic this effect. These observations suggest that hJagged1 may function as a ligand for Notch1 and play a role in mediating cell fate decisions during hematopoiesis.
Subject(s)
Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Membrane Proteins/physiology , Receptors, Cell Surface , Transcription Factors , Adult , Amino Acid Sequence , Animals , COS Cells/metabolism , Calcium-Binding Proteins , Cell Differentiation/physiology , Cell Line , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , DNA, Complementary/metabolism , Gene Expression , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Humans , Intercellular Signaling Peptides and Proteins , Jagged-1 Protein , Membrane Proteins/biosynthesis , Membrane Proteins/genetics , Molecular Sequence Data , Protein Structure, Tertiary , Rats , Receptor, Notch1 , Sequence Homology, Amino Acid , Serrate-Jagged Proteins , Stromal Cells/cytology , Stromal Cells/metabolismABSTRACT
Oligodendrocytes are responsible for myelin formation in spinal cord white matter. In the mature spinal cord, the majority of white matter is localized peripherally. During early development, however, the first oligodendrocyte precursors arise in the ventral ventricular zone of the developing cord. Thus, prior to myelination, both migration and proliferation of oligodendrocyte precursors must occur. When and where these events occur is currently unclear. In the chick spinal cord, oligodendrocyte precursors express antigens recognized by the monoclonal antibody O4. Here we show that all chick spinal cord oligodendrocytes are derived from O4+ cells and all O4+ cells appear to give rise to oligodendrocytes. Analysis of the number and distribution of oligodendrocyte precursors in chick spinal cord at different stages of development suggests that relatively few cells migrate from the ventricular source which then proliferate extensively in white matter. This migration is guided by general dispersive cues. Clonal analysis of oligodendrocyte development in cultures derived from different regions of the rodent spinal cord indicated that the cells that initially populate dorsal and peripheral spinal cord retained similar clonal properties to those in ventral spinal cord, suggesting the migrating cells were immature, highly proliferative precursors. Consistent with these results, BrdU incorporation studies indicate that glial proliferation is extensive and persistent in postnatal rat spinal cord white matter. Together, these studies suggest that spinal cord white matter is initially populated by very immature precursors that then undergo extensive local proliferation prior to myelination.
Subject(s)
Oligodendroglia/physiology , Spinal Cord/cytology , Stem Cells/physiology , Animals , Animals, Newborn/physiology , Cell Division/physiology , Cell Movement/physiology , Cellular Senescence/physiology , Cerebral Ventricles/cytology , Cerebral Ventricles/physiology , Chick Embryo , Cues , Oligodendroglia/cytology , Rats/embryology , Rats/physiology , Stem Cells/cytologyABSTRACT
The electrical properties of adult motoneurons are well matched to the contractile properties of the fast or slow muscle fibers that they innervate. How this precise matching occurs developmentally is not known. To investigate whether motoneurons exhibit selectivity in innervating discrete muscle regions, containing either fast or slow muscle fibers during early neuromuscular development, we caused embryonic chick hindlimb muscles to become innervated by segmentally inappropriate motoneurons. We used the in vitro spinal cord-hindlimb preparation to identify electrophysiologically the pools of foreign motoneurons innervating the posterior iliotibialis (pITIB), an all-fast muscle, and the iliofibularis (IFIB), a partitioned muscle containing discrete fast and slow regions. The results showed that the pITIB and the fast region of the IFIB were exclusively innervated by motoneurons that normally supply fast muscles. In contrast, the slow region of the IFIB was always innervated by motoneuron pools that normally supply slow muscles. Some experimental IFIB muscles lacked a fast region and were innervated solely by "slow" motoneurons. In addition, the intramuscular nerve branching patterns were always appropriate to the fast-slow nature of the muscle (region) innervated. The selective innervation was found early in the motoneuron death period, and we found no evidence that motoneurons grew into appropriate muscle regions, but failed to form functional contacts. Together, these results support the hypothesis that different classes of motoneurons exhibit molecular differences that allow them to project selectively to, and innervate, muscle fibers of the appropriate type during early neuromuscular development.